The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme

Journal of Neurochemistry

Volumn 72, Issue 4, 1999, Pages 1759-1768

  Blázquez, Cristina ^a   Sánchez, Cristina ^a   Daza, Andrés ^a   Galve Roperh, Ismael ^a   Guzmán, Manuel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Astrocytes; Cannabinoids; Carnitine palmitoyltransferase I; Ceramide; Ketone bodies

Indexed keywords

CALCIUM; CANNABINOID; CARNITINE PALMITOYLTRANSFERASE; CERAMIDE; CYCLIC AMP; KETONE BODY; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; RIMONABANT; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; GLUCOSE OXIDATION; HYDROLYSIS; KETOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; RAT;

ANIMALS; ASTROCYTES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CARNITINE O-PALMITOYLTRANSFERASE; CELLS, CULTURED; CEREBRAL CORTEX; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; KETONE BODIES; MALONYL COENZYME A; MITOCHONDRIA; PIPERIDINES; PROTEIN KINASE C; PSYCHOTROPIC DRUGS; PYRAZOLES; RATS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS; SPHINGOSINE; TETRAHYDROCANNABINOL;

ANIMALIA; CANNABIS SATIVA;

EID: 0345561550     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.721759.x     Document Type: Article

References (56)

1. Abood M. E. and Martin B. R. (1992) Neurobiology of marijuana abuse. Trends Pharmacol. Sci. 13, 201-206.
2. Ariga T., Jarvis W. D., and Yu R. K. (1998) Role of sphingomyelin-mediated cell death in neurodegenerative diseases. J. Lipid Res. 39, 1-16.
3. Auestad N., Korsak R. A., Morrow J. W., and Edmond J. (1991) Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J. Neurochem. 56, 1376-1386.
4. Berridge M. J. (1995) Capacitative calcium entry. Biochem. J. 312, 1-11.
5. Bixel M. G. and Hamprecht B. (1995) Generation of ketone bodies from leucine by cultured astroglial cells. J. Neurochem. 65, 2450-2461.
6. Blázquez C., Sánchez C., Velasco G., and Guzmán M. (1998) Role of carnitine palmitoyltransferase 1 in the control of ketogenesis in primary cultures of rat astrocytes. J. Neurochem. 71, 1597-1606.
7. Bouaboula M., Bourrié B., Rinaldi-Carmona M., Shire D., Le Fur G., and Casellas P. (1995a) Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J. Biol. Chem. 270, 13973-13980.
8. Bouaboula M., Poinot-Chazel C., Bourrié B., Canat X., Calandra B., Rinaldi-Carmona M., Le Fur G., and Casellas P. (1995b) Activation of mitogen-activated protein kinase by stimulation of the central cannabinoid receptor CB1. Biochem. J. 312, 637-641.
9. Bouaboula M., Poinot-Chazel C., Marchand J., Canat X., Bourrié B., Rinaldi-Carmona M., Calandra B., Le Fur G., and Casellas P. (1996) Signaling pathway associated with stimulation of the CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur. J. Biochem. 237, 704-711.
10. Bouaboula M., Perrachon S., Milligan L., Canat X., Rinaldi-Carmona M., Portier M., Barth F., Calandra B., Pecceu F., Lupker J., Maffrand J. P., Le Fur G., and Casellas P. (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J. Biol. Chem. 272, 22330-22339.
11. Cullingtbrd T. E., Bhakoo K. K., and Clark J. B. (1998a) Hormonal regulation of the mRNA encoding the ketogenic enzyme mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in neonatal primary cultures of cortical astrocytes and meningeal fibroblasts. J. Neurochem. 71, 1804-1812.
12. Cullingford T. E., Dolphin C. T., Bhakoo K. K., Peuchen S., Canevari L., and Clark J. B. (1998b) Molecular cloning of rat mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase and detection of the corresponding mRNA and of those encoding the remaining enzymes comprising the ketogenic 3-hydroxy-3-methylglutaryl-CoA cycle in central nervous system of suckling rats. Biochem. J. 329, 373-381.
13. David T. S., Ortiz P. A., Smith T. R., and Turinsky J. (1998) Sphingomyelinase has an insulin-like effect on glucose transporter translocation in adipocytes. Am. J. Physiol. 274, R1446-R1453.
14. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J. C., and Piomelli D. (1994) Formation and inactivation of endogenous cannabinoid anandamide. Nature 372, 686-691.
15. Edmond J. (1992) Energy metabolism in developing brain cells. Can. J. Physiol. Pharmacol. 70 (Suppl.), S118-S129.
16. Galve-Ropcrh I., Haro A., and Díaz-Laviada I. (1997) Induction of nerve growth factor synthesis by sphingomyelinase and ceramide in primary astrocyte cultures. Mol. Brain Res. 52, 90-97.
17. Galve-Roperh I., Sánchez C., Ségui B., Haro A., Díaz-Laviada I., and Levade T. (1998) Evidence for the lack of involvement of sphingomyelinase hydrolysis in the tumor necrosis factor-induced secretion of nerve growth factor in primary astrocyte cultures. J. Neurochem. 71, 498-505.
18. Guzmán M. and Geelen M. J. H. (1992) Activity of carnitine palmitoyltransferase in mitochondrial outer membranes and peroxisomes in digitonin-permeabilized hepatocytes. Selective modulation of mitochondrial enzyme activity by okadaic acid. Biochem. J. 287, 487-492.
19. Guzmán M. and Geelen M. J. H. (1993) Regulation of fatty acid oxidation in mammalian liver. Biochim. Biophys. Acta 1167, 227-241.
20. Guzman M., Kolodziej M. P., Caldwell A., Costorphine C. G., and Zammit V. A. (1994) Evidence against direct involvement of phosphorylation in the activation of carnitine palmitoyltransferase by okadaic acid in rat hepatocytes. Biochem. J. 300, 693-699.
21. Guzman M., Bijleveld C., and Geelen M. J. H. (1995) Flexibility of zonation of fatty acid oxidation in rat liver. Biochem. J. 311, 853-860.
22. Hannun Y. A. (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274, 1855-1859.
23. Hillard C. J. and Auchampach J. A. (1994) In vitro activation of brain protein kinase C by the cannabinoids. Biochim. Biophys. Acta 1220, 163-170.
24. Hillard C. J. and Campbell W. B. (1997) Biochemistry and pharmacology of arachidonoylethanolamide, a putative endogenous cannabinoid. J. Lipid Res. 38, 2383-2398.
25. Hinterding K., Alonso-Díaz D., and Waldmann H. (1998) Organic synthesis and biological signal transduction. Angew. Chem. Int. Ed. 37, 688-749.
26. Howlett A. C. (1995) Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35, 607-634.
27. Jung M., Calassi R., Rinaldi-Carmona M., Chardenot P., Le Fur G., Soubrié P., and Oury-Donat F. (1997) Characterization of CB1 receptors on rat neuronal cell cultures: binding and functional studies using the selective receptor antagonist SR 141716A. J. Neurochem. 68, 402-409.
28. Kolesnick R. N. and Krönke M. (1998) Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60, 643-665.
29. Leist M. and Nicotera P. (1998) Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res. 239, 183-201.
30. Magistretti P. J. and Pellerin L. (1996) Cellular bases of brain energy metabolism and their relevance to functional brain imaging. Cereb. Cortex 6, 50-61.
31. McGarry J. D. and Brown N. F. (1997) The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem. 244, 1-14.
32. McKay C. P. (1997) Ceramidase in signal transduction, in Sphingolipid-Mediated Signal Transduction (Hannun Y. A., ed), pp. 173-181. R. G. Landes Co., Austin, Texas.
33. 9-Tetrahydrocannabinol alters cerebral metabolism in a biphasic, dose-dependent manner in rat brain. Eur. J. Pharmacol. 202, 373-378.
34. Morrison D. K. and Cutler R. E. Jr. (1997) The complexity of Raf-1 regulation. Curr. Opin. Cell Biol. 9, 174-179.
35. 2+ channels in a neuronal expression system. Mol. Pharmacol. 49, 707-714.
36. Paumen M. B., Ishida Y., Han H., Muramatsu M., Eguchi Y., Tsujimoto Y., and Honjo T. (1997a) Direct interaction of the mitochondrial membrane protein carnitine palmitoyltransferase I with Bcl-2. Biochem. Biophys. Res. Commun. 231, 523-525.
37. Paumen M. B., Ishida Y., Muramatsu M., Yamainoto M., and Honjo T. (1997b) Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J. Biol. Chem. 272, 3324-3329.
38. Pellerin L., Stolz M., Sorg O., Martin J. C., Deschepper C. F., and Magistretti P. J. (1997) Regulation of energy metabolism by neurotransmitters in astrocytes in primary culture and in an immortalized cell line. Glia 21, 74-83.
39. 2 receptors. Pharmacol. Ther. 74, 129-180.
40. Pertwee R. G. (1997b) Cannabis and cannabinoids: pharmacology and rationale for clinical use. Pharmaceut. Sci. 3, 539-545.
41. Rinaldi-Carmona M., Calandra B., Shire D., Bouaboula M., Oustric D., Barth F., Casellas P., Ferrara P., and Le Fur G. (1996) Characterization of two cloned human CB1 cannabinoid receptor isoforms. J. Pharmacol. Exp. Ther. 278, 871-878.
42. Rinaldi-Carmona M., Barth F., Millan J., Derocq J. M., Casellas P., Cogny C., Oustric D., Sarrau M., Bouaboula M., Calandra B., Portier M., Shire D., Breliere J. C., and Le Fur G. (1998) SR144528, the first potent and selective antagonist of the CB2 receptor. J. Pharmacol. Exp. Ther. 284, 644-650.
43. 9-Tetrahydrocannabinol stimulates glucose utilization in C6 glioma cells. Brain Res. 767, 64-71.
44. 9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett. 436, 6-10.
45. 9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol. Pharmacol. 54, 834-843.
46. Schou J., Prockop L. D., Dahlstrom G., and Rohde C. (1977) Penetration of delta-9-tetrahydrocannabinol and 11-OH-delta-9-tetrahydrocannabinol through the blood-brain barrier. Acta Pharmacol. Toxicol. 41, 33-38.
47. Showalter V. M., Compton D. R., Martin B. R., and Abood M. E. (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 278, 989-999.
48. Skaper S. D., Buriani A., Del Toso R., Petrelli L., Romanello S., Facci L., and Leon A. (1996) The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc. Natl. Acad. Sci. USA 93, 3984-3989.
49. Velasco G., Sánchez C., Geelen M. J. H., and Guzmán M. (1996) Are cytoskeletal components involved in the control of hepatic carnitine palmitoyltransferase I activity? Biochem. Biophys. Res. Commun. 224, 754-759.
50. 2+/calmodulin-dependent protein kinase II and cytoskeletal components. J. Biol. Chem. 273, 21497-21504.
51. Velasco G., Passilly P., Guzmán M., and Latruffe N. (1998b) Loss of response of carnitine palmitoyltransferase I to okadaic acid in transformed hepatic cells. Biochem. Pharmacol. 56, 1485-1488.
52. Venance L., Piomelli D., Glowinski J., and Giaume C. (1995) Inhibition by anandamide of gap junctions and intracellular calcium signaling in striatal astrocytes. Nature 376, 590-594.
53. Volkow N. D., Gillespie H., Mullani N., Tancredi L., Grant C., Valentine A., and Hollister L. (1996) Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatry Res. Neuroimaging 67, 29-38.
54. Wang C. N., O'Brien L., and Brindley D. N. (1998) Effects of cell-permeable ceramides and tumour necrosis factor-α on insulin signaling and glucose uptake in 3T3-L1 adipocytes. Diabetes 47, 24-31.
55. Wiesinger H., Hamprecht B., and Dringer R. (1997) Metabolic pathways for glucose in astrocytes. Glia 21, 22-34.
56. Zammit V. A. (1994) Regulation of ketone body metabolism. A cellular perspective. Diabetes Rev. 2, 132-155.